Mullighan: New subtypes - MEF2D-rearr B-ALL, RNA-seq of 560 B-ALL cases, multiple recurring targets MEF2D, ZNF384, NUTM1, IGH. #AMP2017

12:34pm November 16th 2017 via Hootsuite